ArticleIrish journal of medical science2023

Efficacy and safety of neoadjuvant pyrotinib plus docetaxel/liposomal doxorubicin/cyclophosphamide for HER2-positive breast cancer.

Chunyu Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.